Answers are grounded in this paper and cite their sources.
Matrix metalloproteinase-9 (MMP9) plays an important role in extracellular matrix remodeling and has been implicated in tumor invasion and metastasis in several cancers, including breast cancer (BC). This study aims to elucidate the genetic factors influencing breast cancer risk by analyzing the role of MMP9 (rs17576 and rs3787268) variants in cancer susceptibility. We employed a holistic methodology that integrates genetic analysis with sophisticated bioinformatics techniques to elucidate their potential influence on the progression of breast carcinoma using multi-platform functional evidence. A case–control study was conducted including 120 breast cancer patients and 120 age-matched healthy controls. Genotyping of rs17576 and rs3787268 was performed using TaqMan allelic discrimination assays. Logistic regression models were applied to evaluate genotype, allele, and haplotype associations with breast cancer susceptibility. Complementary bioinformatic analyses (GEPIA2, GTEx, TNMplot, muTarget, STRING, I-Mutant, and 3DSNP) were performed to investigate gene expression patterns, eQTL effects, protein stability, and potential molecular interactions. The missense variant MMP9*rs17576 showed a significant association with breast cancer susceptibility under several genetic models (A/G: OR = 2.31, 95% CI = 1.24–4.29, p = 0.007; and G/G: OR = 2.46, 95% CI = 1.16–5.22, p = 0.017). The G allele frequency was higher in patients than in controls (52.5% vs. 41.2%; OR = 1.57, 95% CI = 1.10–2.26, p = 0.013). In contrast, the intronic variant MMP9*rs3787268 showed no independent association with breast cancer susceptibility. Bioinformatic analyses suggested that rs17576 may influence MMP9 function and regulation, including predicted protein destabilization (ΔΔG = − 0.34 kcal/mol), breast-tissue eQTL effects, and potential involvement in tumor-related molecular pathways. Expression analyses also indicated increased MMP9 expression in breast cancer tissues and association with disease progression. These findings suggest that the MMP9*rs17576 variant may contribute to breast cancer susceptibility in Egyptian women, whereas MMP9*rs3787268 showed no independent association. Given the single-population design, these results should be interpreted cautiously and require validation in larger, ethnically diverse cohorts together with functional investigations.
No takes yet. Share an insight, caveat, or question.
Zidan et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: